China last week announced it was done retaliating against U.S. President Donald Trump’s tariffs, saying any further increases ...

Beijing has wielded a wide range of punitive measures in recent days to strike back at Washington, including steps targeting ...

The White House said Tuesday that "the ball is in China's court," as far as a trade deal with the U.S. is concerned.

BofA lowered the firm’s price target on Illumina (ILMN) to $75 from $90 and keeps an Underperform rating on the shares. Sentiment for Life ...

The White House said Tuesday that "the ball is in China's court," as far as a trade deal with the U.S. is concerned.

Beijing has urged the US to remove the tariffs and resolve differences through dialogue. Read more at straitstimes.com. Read ...

As commented in this article, Illumina said that 7% of its global revenues were from China. In addition, China prohibited Illumina from importing gene sequencer machines to that country.

Illumina has been caught in the middle of a tariff war between the U.S. and China that has compelled it to cut its annual forecast and implement a cost-savings plan. China, which accounts for 7% ...

China responded to President Trump’s trade war with increased tariffs and economic restrictions on certain U.S. firms ...

Illumina has been caught in the middle of a tariff war between the U.S. and China that has compelled it to cut its annual forecast and implement a cost-savings plan. China, which accounts for 7% ...

The changes come at a time when Illumina (ILMN) is facing the consequences of a U.S.-China trade war and months after the divestment of its 2021 acquisition of Grail cancer test developer ...

If Trump escalates, China has a banquet of spicy options to choose from. Illumina lowers outlook due to China sales ban, to cut $100 million in costs Illumina on Monday lowered its annual forecast ...